2013 Food and Drug Administration Pharmaceutical manufacturing 
European Pharmaceutical Review
NOVEMBER 8, 2022
In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 5) monitoring access to biosimilars.
European Pharmaceutical Review
APRIL 8, 2025
Implementing PAT in (bio)pharmaceutical manufacturing New sensors or larger equipment with more complex setups (software and hardware) require stringent procedures to become fully implemented in a good manufacturing practice (GMP) manufacturing facility. Q13 Continuous Manufacturing of Drug Substances and Drug Products.
Expert insights. Personalized for you.
52 
Let's personalize your content